Skip to main content
Clinical Trials/JPRN-jRCTs031200291
JPRN-jRCTs031200291
Recruiting
Phase 3

A clinical study on the efficacy and safety of silkworm Cordyceps for cognitive function in patients with dementia

Hiroyuki Osawa0 sites40 target enrollmentJanuary 13, 2021

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Hiroyuki Osawa
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 13, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hiroyuki Osawa

Eligibility Criteria

Inclusion Criteria

  • Dementia over the preceding 6 months as the following criteria
  • 1\.Persons with an MMSE result of 21 or less
  • 2\.Those who are not in the habit of taking foods containing Cordyceps
  • 3\.Those who do not regularly use supplements and health foods
  • 4\.Those who have no history of treatment for malignant tumor, heart failure, myocardial infarction
  • 5\.Those who are not allergic to foods and medicines containing Cordyceps
  • 6\.Those who fully understand the content of clinical trials and have written consent

Exclusion Criteria

  • 1\.Pregnant or breast\-feeding woman or person who is willing to become pregnant during the test period
  • 2\.Those who are participating in other clinical trials and those who have participated in other clinical trials within 3 months
  • 3\.Those who cannot follow the instructions of the physicians and medical staff
  • 4\.A person who has been judged by a physicians to have any problems

Outcomes

Primary Outcomes

Not specified

Similar Trials